Table 6.

Incremental cost-effectiveness ratios, healthcare perspective, 0 to 6 months

	Incremental cost			Incremental effect			ICER
	Mean; (95% bootstrap CI)			Mean; (95% bootstrap CI)
CBT versus TAU
Completers ( N =152)
QALY (EQ-5D)	−1,577.6	−2,601.8	−553.4	0.01	−0.00	0.03	CBT dominant
EQ VAS	−1,583.8	−2,606.9	−560.7	6.19	3.63	8.75	CBT dominant
ITT ( N =168)
QALY (EQ-5D)	−1,632.6	−2,744.6	−520.7	0.02	−0.00	0.03	CBT dominant
EQ VAS	−1,635.0	−2,747.6	−522.3	6.33	3.59	9.07	CBT dominant
PPA ( N =154)
QALY (EQ-5D)	−1,773.5	−2,924.9	−622.1	0.02	−0.00	0.03	CBT dominant
EQ VAS	−1,775.1	−2,927.6	−622.7	6.58	3.83	9.33	CBT dominant
CBT versus RPT
Completers ( N =152)
QALY (EQ-5D)	−1,866.8	−2,917.6	−816.0	0.01	−0.00	0.03	CBT dominant
EQ VAS	−1,870.8	−2,921.6	−819.9	3.52	1.13	5.91	CBT dominant
ITT ( N =168)
QALY (EQ-5D)	−1,804.0	−2,786.7	−821.3	0.01	−0.00	0.03	CBT dominant
EQ VAS	−1,805.4	−2,788.6	−822.2	3.61	1.08	6.15	CBT dominant
PPA ( N =154)
QALY (EQ-5D)	−1,972.8	−3,008.2	−937.5	0.01	−0.00	0.03	CBT dominant
EQ VAS	−1,973.7	−3,011.3	−936.1	3.93	1.35	6.52	CBT dominant
RPT versus TAU
Completers ( N =152)
QALY (EQ-5D)	289.2	−858.1	1,436.5	−0.00	−0.02	0.01	TAU dominant
EQ VAS	287.0	−857.3	1,431.2	2.67	0.55	4.79	107
ITT ( N =168)
QALY (EQ-5D)	171.4	−1,037.3	1,380.0	0.00	−0.01	0.02	98,434
EQ VAS	170.4	−1,037.1	1,377.9	2.72	0.42	5.02	63
PPA ( N =154)
QALY (EQ-5D)	199.3	−1,023.0	1,421.6	0.00	−0.01	0.02	107,697
EQ VAS	198.6	−1,022.6	1,419.7	2.65	0.35	4.94	75